Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy (original) (raw)
References
Zhang, L. et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med.348, 203–213 (2003). ArticleCAS Google Scholar
Sato, E. et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. USA102, 18538–18543 (2005). ArticleCAS Google Scholar
Hamanishi, J. et al. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proc. Natl. Acad. Sci. USA104, 3360–3365 (2007). ArticleCAS Google Scholar
Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science313, 1960–1964 (2006). ArticleCAS Google Scholar
Buckanovich, R.J. et al. Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment. Cancer Biol. Ther.5, 635–642 (2006). ArticleCAS Google Scholar
Espina, V. et al. Laser-capture microdissection. Nat. Protoc.1, 586–603 (2006). ArticleCAS Google Scholar
Buckanovich, R.J. et al. Tumor vascular proteins as biomarkers in ovarian cancer. J. Clin. Oncol.25, 852–861 (2007). ArticleCAS Google Scholar
Levin, E.R. Endothelins as cardiovascular peptides. Am. J. Nephrol.16, 246–251 (1996). ArticleCAS Google Scholar
D'Orleans-Juste, P. et al. Function of the endothelin B receptor in cardiovascular physiology and pathophysiology. Pharmacol. Ther.95, 221–238 (2002). ArticleCAS Google Scholar
Bagnato, A., Spinella, F. & Rosano, L. Emerging role of the endothelin axis in ovarian tumor progression. Endocr. Relat. Cancer12, 761–772 (2005). ArticleCAS Google Scholar
Fukami, T. et al. Synthesis and structure-activity relationships of 2-substituted D-tryptophan–containing peptidic endothelin receptor antagonists: importance of the C-2 substituent of the D-tryptophan residue for endothelin A and B receptor subtype selectivity. J. Med. Chem.39, 2313–2330 (1996). ArticleCAS Google Scholar
Tsukahara, H., Ende, H., Magazine, H.I., Bahou, W.F. & Goligorsky, M.S. Molecular and functional characterization of the non–isopeptide-selective ETB receptor in endothelial cells. Receptor coupling to nitric oxide synthase. J. Biol. Chem.269, 21778–21785 (1994). CASPubMed Google Scholar
Bouzin, C., Brouet, A., De Vriese, J., Dewever, J. & Feron, O. Effects of vascular endothelial growth factor on the lymphocyte-endothelium interactions: identification of caveolin-1 and nitric oxide as control points of endothelial cell anergy. J. Immunol.178, 1505–1511 (2007). ArticleCAS Google Scholar
Nelson, J., Bagnato, A., Battistini, B. & Nisen, P. The endothelin axis: emerging role in cancer. Nat. Rev. Cancer3, 110–116 (2003). ArticleCAS Google Scholar
Zhang, L. et al. Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. Am. J. Pathol.161, 2295–2309 (2002). ArticleCAS Google Scholar
Courreges, M.C., Benencia, F., Conejo-Garcia, J.R., Zhang, L. & Coukos, G. Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines. Cancer Gene Ther.13, 182–193 (2006). ArticleCAS Google Scholar
Peng, X., Treml, J. & Paterson, Y. Adjuvant properties of listeriolysin O protein in a DNA vaccination strategy. Cancer Immunol. Immunother.56, 797–806 (2007). ArticleCAS Google Scholar
Hodi, F.S. & Dranoff, G. Combinatorial cancer immunotherapy. Adv. Immunol.90, 341–368 (2006). ArticleCAS Google Scholar
Korman, A.J., Peggs, K.S. & Allison, J.P. Checkpoint blockade in cancer immunotherapy. Adv. Immunol.90, 297–339 (2006). ArticleCAS Google Scholar
Schlom, J., Arlen, P.M. & Gulley, J.L. Cancer vaccines: moving beyond current paradigms. Clin. Cancer Res.13, 3776–3782 (2007). ArticleCAS Google Scholar
Gattinoni, L., Powell, D.J., Jr., Rosenberg, S.A. & Restifo, N.P. Adoptive immunotherapy for cancer: building on success. Nat. Rev. Immunol.6, 383–393 (2006). ArticleCAS Google Scholar
Huddleston, H.G., Wong, K.K., Welch, W.R., Berkowitz, R.S. & Mok, S.C. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker. Gynecol. Oncol.96, 77–83 (2005). ArticleCAS Google Scholar
Marasciulo, F.L., Montagnani, M. & Potenza, M.A. Endothelin-1: the yin and yang on vascular function. Curr. Med. Chem.13, 1655–1665 (2006). ArticleCAS Google Scholar
Salani, D. et al. Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am. J. Pathol.157, 1703–1711 (2000). ArticleCAS Google Scholar
Motte, S., McEntee, K. & Naeije, R. Endothelin receptor antagonists. Pharmacol. Ther.110, 386–414 (2006). ArticleCAS Google Scholar
Wanecek, M., Weitzberg, E., Rudehill, A. & Oldner, A. The endothelin system in septic and endotoxin shock. Eur. J. Pharmacol.407, 1–15 (2000). ArticleCAS Google Scholar
Sampaio, A.L., Rae, G.A. & Henriques, M.M. Role of endothelins on lymphocyte accumulation in allergic pleurisy. J. Leukoc. Biol.67, 189–195 (2000). ArticleCAS Google Scholar
Sampaio, A.L., Rae, G.A. & Henriques, M.G. Effects of endothelin ETA receptor antagonism on granulocyte and lymphocyte accumulation in LPS-induced inflammation. J. Leukoc. Biol.76, 210–216 (2004). ArticleCAS Google Scholar
Wulfing, P. et al. Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up. Clin. Cancer Res.9, 4125–4131 (2003). PubMed Google Scholar
Grimshaw, M.J. et al. A role for endothelin-2 and its receptors in breast tumor cell invasion. Cancer Res.64, 2461–2468 (2004). ArticleCAS Google Scholar
Kuhlmann, A., Amann, K., Schlotzer-Schrehardt, U., Kruse, F.E. & Cursiefen, C. Endothelin-1 and ETA-ETB receptor protein and mRNA: expression in normal and vascularized human corneas. Cornea24, 837–844 (2005). Article Google Scholar
Wagner, O.F. et al. Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem.267, 16066–16068 (1992). CASPubMed Google Scholar
Wedgwood, S. & Black, S.M. Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor–mediated generation of hydrogen peroxide. Am. J. Physiol. Lung Cell. Mol. Physiol.288, L480–L487 (2005). ArticleCAS Google Scholar
Bagnall, A.J. et al. Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension48, 286–293 (2006). ArticleCAS Google Scholar
Halcox, J.P., Nour, K.R., Zalos, G. & Quyyumi, A.A. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B. Hypertension49, 1134–1141 (2007). ArticleCAS Google Scholar
Cardillo, C., Kilcoyne, C.M., Waclawiw, M., Cannon, R.O., III & Panza, J.A. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension33, 753–758 (1999). ArticleCAS Google Scholar
Kubes, P. Inducible nitric oxide synthase: a little bit of good in all of us. Gut47, 6–9 (2000). ArticleCAS Google Scholar
Gauthier, T.W., Davenpeck, K.L. & Lefer, A.M. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am. J. Physiol.267, G562–G568 (1994). CASPubMed Google Scholar
Lelamali, K., Wang, W., Gengaro, P., Edelstein, C. & Schrier, R.W. Effects of nitric oxide and peroxynitrite on endotoxin-induced leukocyte adhesion to endothelium. J. Cell. Physiol.188, 337–342 (2001). ArticleCAS Google Scholar
Cowburn, P.J. et al. Comparison of selective ETA and ETB receptor antagonists in patients with chronic heart failure. Eur. J. Heart Fail.7, 37–42 (2005). ArticleCAS Google Scholar
Baatz, H. & Pleyer, U. Modulation of leukocyte-endothelium interaction by nitric oxide synthase inhibitors: effects on leukocyte adhesion in endotoxin-induced uveitis. Inflamm. Res.50, 534–543 (2001). ArticleCAS Google Scholar
Hickey, M.J. Role of inducible nitric oxide synthase in the regulation of leucocyte recruitment. Clin. Sci. (Lond.)100, 1–12 (2001). ArticleCAS Google Scholar
Feuerer, M., Eulenburg, K., Loddenkemper, C., Hamann, A. & Huehn, J. Self-limitation of Th1-mediated inflammation by IFN-γ. J. Immunol.176, 2857–2863 (2006). ArticleCAS Google Scholar
Waldow, T., Witt, W., Weber, E. & Matschke, K. Nitric oxide donor–induced persistent inhibition of cell adhesion protein expression and NF-κB activation in endothelial cells. Nitric Oxide15, 103–113 (2006). ArticleCAS Google Scholar
Kelleher, Z.T., Matsumoto, A., Stamler, J.S. & Marshall, H.E. NOS2 regulation of NF-κB by _S_-nitrosylation of p65. J. Biol. Chem.282, 30667–30672 (2007). ArticleCAS Google Scholar
López, A. et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med.32, 21–30 (2004). Article Google Scholar
Ng, Q.S. et al. Effect of nitric oxide synthesis on tumour blood volume and vascular activity: a phase 1 study. Lancet Oncol.8, 111–118 (2007). ArticleCAS Google Scholar
Iqbal, J., Sanghia, R. & Das, S.K. Endothelin receptor antagonists: an overview of their synthesis and structure-activity relationship. Mini Rev. Med. Chem.5, 381–408 (2005). ArticleCAS Google Scholar
Morris, C.D. et al. Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence. Br. J. Cancer92, 2148–2152 (2005). ArticleCAS Google Scholar
Conejo-Garcia, J.R. et al. Vascular leukocytes contribute to tumor vascularization. Blood105, 679–681 (2005). ArticleCAS Google Scholar